Zoono Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZOONF research report →
Companyzoono.com
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors.
- CEO
- Paul Hyslop
- IPO
- 2020
- Employees
- 1
- HQ
- Auckland, NZ
Price Chart
Valuation
- Market Cap
- $17.71M
- P/E
- -8.62
- P/S
- 32.90
- P/B
- 8.71
- EV/EBITDA
- -10.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -74.60%
- Op Margin
- -328.28%
- Net Margin
- -369.36%
- ROE
- -108.90%
- ROIC
- -61.56%
Growth & Income
- Revenue
- $749.85K · -21.92%
- Net Income
- $-2,354,930 · 71.69%
- EPS
- $-0.01 · 82.59%
- Op Income
- $-1,753,613
- FCF YoY
- 76.45%
Performance & Tape
- 52W High
- $0.05
- 52W Low
- $0.01
- 50D MA
- $0.04
- 200D MA
- $0.03
- Beta
- 1.15
- Avg Volume
- 16
Get TickerSpark's AI analysis on ZOONF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ZOONF Coverage
We haven't published any research on ZOONF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZOONF Report →